A detailed history of Addenda Capital Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Addenda Capital Inc. holds 49,107 shares of ABT stock, worth $5.11 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
49,107
Previous 49,244 0.28%
Holding current value
$5.11 Million
Previous $5.42 Million 2.97%
% of portfolio
0.29%
Previous 0.28%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$109.52 - $120.96 $15,004 - $16,571
-137 Reduced 0.28%
49,107 $5.58 Million
Q4 2023

Jan 23, 2024

SELL
$90.19 - $110.4 $4,509 - $5,520
-50 Reduced 0.1%
49,244 $5.42 Million
Q3 2023

Oct 12, 2023

SELL
$95.53 - $114.62 $4,394 - $5,272
-46 Reduced 0.09%
49,294 $4.77 Million
Q2 2023

Jul 21, 2023

SELL
$100.78 - $112.29 $2,015 - $2,245
-20 Reduced 0.04%
49,340 $5.38 Million
Q1 2023

Apr 11, 2023

SELL
$96.86 - $114.01 $36,903 - $43,437
-381 Reduced 0.77%
49,360 $5 Million
Q4 2022

Jan 12, 2023

SELL
$95.06 - $111.52 $61,123 - $71,707
-643 Reduced 1.28%
49,741 $0
Q3 2022

Oct 11, 2022

BUY
$96.76 - $112.03 $4.88 Million - $5.64 Million
50,384 New
50,384 $4.88 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Addenda Capital Inc. Portfolio

Follow Addenda Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addenda Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Addenda Capital Inc. with notifications on news.